Inotiv, Inc. (NOTV) intrinsic value & 10-year financials

Inotiv, Inc. (NOTV) has a Graham intrinsic value of $6.31 per share. Over the last 10 fiscal years revenue grew 43.1% a year to $513.0M, with an average return on invested capital of -12.1%.

Graham intrinsic value
$6.31
Revenue (FY2025)
$513.0M
Revenue growth (10-yr CAGR)
43.1%
ROIC (10-yr avg)
-12.1%
Free cash flow (FY2025)
-$27.1M

NOTV 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $513.0M -$68.6M -$2.11 -$27.1M -6.0% -4.2%
FY2024 $490.7M -$108.4M -$4.19 -$29.1M -17.6% -11.7%
FY2023 $572.4M -$105.1M -$4.10 $380.0K -14.2% -10.2%
FY2022 $547.7M -$337.0M -$13.84 -$41.5M -48.1% -59.9%
FY2021 $89.6M $10.9M $0.19 -$1.7M -6.3% -6.6%
FY2020 $60.5M -$4.7M -$0.43 -$4.9M -5.1% -10.3%
FY2019 $43.6M -$790.0K -$0.08 -$5.1M -0.4% -0.7%
FY2018 $26.3M -$194.0K -$0.02 $2.2M 0.1% 0.1%
FY2017 $24.2M $884.0K $0.10 $889.0K 5.3% 10.7%
FY2016 $20.4M -$3.2M -$0.40 -$196.0K -14.9% -28.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Inotiv, Inc. is a consistent compounder, expanding top-line revenue at 43.1% annually over the past decade.

Inotiv, Inc. has historically struggled to out-earn its cost of capital, averaging just -12.1% ROIC.

Over the decade, Inotiv, Inc. shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Inotiv, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $6.31 per share.

NOTV stock: frequently asked questions

What is the intrinsic value of Inotiv, Inc. (NOTV) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, NOTV's intrinsic value is about $6.31 per share.

How fast has Inotiv, Inc. grown?

Revenue went from $20.4M in fiscal 2016 to $513.0M in fiscal 2025, a compound annual growth rate of 43.1%. Net income was -$68.6M in fiscal 2025.

Does Inotiv, Inc. generate free cash flow?

Inotiv, Inc. generated -$27.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 10 reported years.

What is NOTV's return on invested capital?

Average ROIC over the last 10 fiscal years was -12.1%, and average return on equity was -34.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NOTV data come from?

From Inotiv, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 11, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar commercial physical & biological research stocks